Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents

Nutrition

Volumn 31, Issue 1, 2015, Pages 90-96

  Machado, Adriane M ^a   de Paula, Heberth ^a   Cardoso, Luciane Daniele ^a   Costa, Neuza M B ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Adolescents; Flaxseed; Overweight; Physiological effects

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; CHOLESTEROL; GAMMA INTERFERON; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; LINOLENIC ACID;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; BROWN FLAXSEED; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GOLDEN FLAXSEED; HUMAN; INFLAMMATION; LINSEED; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WHEAT BRAN; ADMINISTRATION AND DOSAGE; BLOOD; BODY MASS; BRAZIL; CHEMISTRY; DIET THERAPY; DIETARY FIBER; DRUG EFFECTS; FLAX; METABOLISM; WAIST CIRCUMFERENCE;

LINUM USITATISSIMUM; TRITICUM AESTIVUM;

ADIPONECTIN; ADOLESCENT; ALPHA-LINOLENIC ACID; BIOMARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; BRAZIL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FIBER; FEMALE; FLAX; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; OVERWEIGHT; SINGLE-BLIND METHOD; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE;

EID: 84922242097     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.05.002     Document Type: Article

References (56)

1. Instituto Brasileiro de Geografia e Estatística. Pesquisa de orçamentos familiares, 2008 to 2009: Antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. accessed July 2013;2010. http://www.ibge.gov.br/home/estatistica/populacao/condicaodevida/pof/2008_2009_encaa.
2. The use and interpretation of anthropometry physical status: The use and interpretation of anthropometry: Report of a WHO expert committee 1995, World Health Organization, WHO, Geneva.
3. Mello E.D., Luft V., Meyer F. Obesidade infantil: Como podemos ser eficazes?. J Pediatr 2004, 80:173-182. [in Portuguese].
4. Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444(7121):875-880.
5. Zulet M.A., Puchau B., Navarro C., Martí A., Martínez J.A. Biomarcadores del estado inflamatorio: Nexo de unión con la obesidad y complicaciones asociadas. Nutr Hosp 2007, 22(5):511-527. [in Spanish].
6. Rana J.S., Nieuwdorp M., Jukema J.W., Kastelein J.J. Cardiovascular metabolic syndrome - an interplay of obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab 2007, 9:218-232.
7. Nutrition in adolescence: Issues and challenges for the health sector: Issues in adolescence health and development 2004, World Health Organization, WHO, Geneva.
8. Morris D. Flax - A Health and Nutrition Primer. = primer&mp = nutrition. (accessed Dec 2013);2007. http://www.flaxcouncil.ca/english/index.jsp?P.
9. Pan A., Yu D., Demark-Wahnefried W., Franco O.H., Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 2009, 90(2):288-297.
10. Dodin S., Lemay A., Jacques H., Légaré F., Forest J.C., Mâsse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: A randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005, 90:1390-1397.
11. Cintra D.E., Costa A.V. Peluzio M do C, Matta SL, Silva MT, Costa NM. Lipid profile of rats fed high-fat diets based on flaxseed, peanut, trout, or chicken skin. Nutrition 2006, 22:197-205.
12. Wu H., Pan A., Yu Z., Qi Q., Lu L., Zhang G., et al. Lifestyle counseling and supplementation with flaxseed or walnuts infiuence the management of metabolic syndrome. J Nutr 2010, 140:1937-1942.
13. Lucas E.A., Lightfoot S.A., Hammond L.J., Devareddy L., Khalil D.A., Daggy B.P., et al. Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 2004, 173:223-229.
14. Zhang W., Wang X., Liu Y., Tian H., Flickinger B., Empie M.W., et al. Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 2008, 99:1301-1309.
15. Wu H., Pan A., Yu Z., Qi Q., Lu L., Zhang G., et al. Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. J Nutr 2010, 140:1937-1942.
16. Couto A.N., Wichmann F.M.A. Efeitos da farinha da linhaça no perfil lipídico e antropométrico de mulheres. Alim Nutr 2011, 22:601-608.
17. Epaminondas P.S., Araujo K.L.G.V., de Souza A.L., Silva M.C.D., Queiroz N., Souza A.L., et al. Influence of toasting on the nutritious and thermal properties of flaxseed. J Therm Anal Calorim 2011, 106:551-555.
18. Sargi S.C., Silva B.C., Santos H.M.C., Montanher P.F., Boeing J.S., Santos Júnior O.O., et al. Antioxidant capacity and chemical composition in seeds rich in omega-3: Chia, flax, and perilla. Food Sci Technol 2013, 33:541-548.
19. Ayres A.M., Ayres M., Ayres D.L., Santos A.A.S. BioEstat: Aplicações estatísticas nas áreas das ciências bio-médicas. Belém-PA 2007, 364. 5th ed.
20. Tabela Brasileira de Composição de Alimentos - TACO. 4. ed. revisada e ampliada. Campinas: NEPA- UNICAMP;2011.
21. Philippi, S.T. Tabela de composição de alimentos: Suporte para decisão nutricional. 2. ed.2002.
22. World Health Organization. Growth reference 5 to 19 y. (accessed May 2011);2007. http://www.who.int/growthref/en.
23. World Health Organization Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation 2000, WHO, Geneva.
24. Anthropometric standardization reference manual 1988, Human Kinetics, Champaign (IL). T.G. Lohman, A.F. Roche, R. Martorell (Eds.).
25. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. USDHHS 2005, US Department of Health and Human Services.
26. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
27. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
28. US Food and Drug Administration. Guidance for Industry: A Food Labeling Guide. (accessed May 2014);2013. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm064923.htm.
29. McKiernan F., Lokko P., Kuevi A., Sales R.L., Costa N.M., Bressan J., et al. Effects of peanut processing on body weight and fasting plasma lipids. Br J Nutr 2010, 104(3):418-426.
30. Pineda A.M.R., Gómez B.L.G., Alzate C.M.A., Castaño C.F.M., Marín B.E.L. Consumo de linaza molida para la reducción de peso corporal en personas con exceso de peso. Perspect Nutr Hum 2011, 13:45-56.
31. Daun J.K., Barthet V.L., Chornick T.L., Duguid S. Structure, composition, and variety development of flaxseed. Flaxseed in human nutrition 2003, 1-40. second ed. L.U. Thompson, S.C. Cunnane (Eds.).
32. Hassanali Z., Ametaj B.N., Field C.J., Proctor S.D., Vine D.F. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR: LA-cp rat. Diabetes Obes Metab 2010, 12:139-147.
33. Marques A.C., Hautrive T.P., Moura G.B., Callegaro M.G.K., Hecktheuer L.H.R. Efeito da linhaça (Linum usitatissimum L.) sob diferentes formas de preparo na resposta biológica em ratos. Rev Nutr 2011, 24:131-141.
34. Murase T., Ioki M., Tokimitsu I. Supplementation with alpha-linolenic acid rich diacylglycerol suppresses fatty liver formation accompanied by an upregulation of β-oxidation in Zucker rats. Biochet Biophyfica Acta 2005, 1733:224-231.
35. Tai C.C., Ding S.T. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: Mechanisms and implications for obesity prevention. J Nutr Biochem 2010, 21:357-363.
36. Mandaşescu S., Mocanu V., Dăscaliţa A.M., Haliga R., Nestian I., Stitt P.A., et al. Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat Iasi 2005, 109:502-506.
37. Bloedon L.T., Balikai S., Chittams J., Cunnane S.C., Berlin J.A., Rader D.J., et al. Flaxseed and cardiovascular risk factors: Results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 2008, 27:65-74.
38. Rhee Y., Brunt A. Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: A randomized crossover design. J Nutr 2011, 10:1-7.
39. Holness M.J., Smith N.D., Greenwood G.K., Sugden M.C. Acute w-3 fatty acid enrichment selectively reverses high-saturated fat feeding-induced insulin hypersecretion but does not improve peripheral insulin resistance. Diabetes 2004, 53(Suppl 1):S166-S171.
40. Taylor C.G., Noto A.D., Stringer D.M., Froese S., Malcolmson L. Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr 2010, 29:72-80.
41. Paschos G.K., Magkos F., Panagiotakos D.B., Votteas V., Zampelas A. Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 2007, 61:1201-1206.
42. Cornish S.M., Chilibeck P.D., Paus-Jennsen L., Biem H.J., Khozani T., Senanayake V., et al. A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 2009, 34:89-98.
43. Begg D.P., Sinclair A.J., Stahl L.A., Premaratna S.D., Hafandi A., Jois M., et al. Hypertension induced by omega-3 polyunsaturated fatty acid deficiency is alleviated by alpha-linolenic acid regardless of dietary source. Hypertens Res 2010, 33:808-813.
44. Jones D.S. Textbook of functional medicine 2005, 820. Institute of Functional Medicine, Gig Harbor.
45. El-Atat F.A., Stas S.N., McFarlane S.I., Sowers J.R. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004, 15:2816-2827.
46. Groop P.H., Forsblom C., Thomas M.C. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Pract Endocrinol Metab 2005, 1:100-110.
47. Bere E. Wild berries: A good source of omega-3. Eur J Clin Nutr 2007, 61:431-433.
48. Pawlosky R.J., Hibbeln J.R., Lin Y., Goodson S., Riggs P., Sebring N., et al. Effects of beef and fish based diets on the kinetics of n-3 fatty acid metabolism in human subjects. Am J Clin Nutr 2003, 77:565-572.
49. Calder P.C., Albers R., Antoine J.M., Blum S., Bourdet-Sicard R., Ferns G.A., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009, 101(Suppl 1):S1-45.
50. Kivelä A.M., Kansanen E., Jyrkkänen H.K., Nurmi T., Ylä-Herttuala S., Levonen A.L. Enterolactone induces heme oxygenase-1 expression trough nuclear factor E2 related factor 2 activation in endothelial cells. J Nutr 2008, 138:1263-1268.
51. Ogawa F., Shimizu K., Muroi E., Hara T., Hasegawa M., Takehara K., et al. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology 2006, 45:815-818.
52. Hallund J., Tetens I., Bügel S., Tholstrup T., Bruun J.M. The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis 2008, 18:497-502.
53. Cohen S.L., Ward W.E. Flaxseed oil and bone development in growing male and female Mice. J Toxicol Environ Health A 2005, 68:1861-1870.
54. Pan A., Sun J., Chen Y., Ye X., Li H., Yu Z., et al. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: A randomized, double-blind, crossover trial. PLoS ONE 2007, 2:e1148.
55. Faintuch J., Schmidt V.D., Horie L.M., Barbeiro H.V., Barbeiro D.F., Soriano F.G., et al. Propriedades antiinflamatórias da farinha de linhaça em pacientes obesos. Rev Bras Nutr Clin 2006, 21:273-277.
56. Barre D.E., Mizier-Barre K.A., Stelmach E., Hobson J., Griscti O., Rudiuk A., et al. Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis - an invitation to further investigation into polypharmacy reduction. J Nutr Metab 2012, 2012:585170.